PALIPERIDONE BIOGARAN 50 mg, suspension for injection with extended release in a pre-filled syringe syringe
Active ingredients: PALIPÉRIDONE, Paliperidone palmitate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Suspension for injection with extended releasesyringeintramusculaire
Marketing discontinued
Package details
Original BDPM fields are shown in French.
- Official name
- PALIPERIDONE BIOGARAN 50 mg, suspension injectable à libération prolongée en seringue préremplie
- Pharmaceutical form
- suspension injectable à libération prolongée
- Route of administration
- intramusculaire
- Presentation description
- 1 seringue préremplie polycyclooléfine avec 2 aiguilles
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 14 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65593826CIP73024090CIP133400930240908Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PALIPÉRIDONEsuspension | 50 mg · une seringue préremplie | FT |
| PALMITATE DE PALIPÉRIDONEsuspension | 78 mg · une seringue préremplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.